1yr
Sleep Disorder Connect
1yr
The 2025 APA Resource Document explores catatonia’s history, prevalence, diagnostics, differential diagnoses, and treatment—including benzodiazepines and ECT. It also addresses special populations like pediatrics, pregnancy, dementia, and outlines ethical/legal concerns.
1yr
Did you know? The American Psychiatric Association recommends structured psychotherapy—like Dialectical Behavior Therapy and Mentalization-Based Treatment—as the gold standard for Borderline Personality Disorder, with medication used only for specific symptoms and always alongside therapy. Person-centered plans and collaboration are key.
Did you know that clinicians are encouraged to use standardized symptom scales at the start of BPD treatment to track progress over time?
Did you know that clinicians are encouraged to use standardized symptom scales at the start of BPD treatment to track progress over time?
1yr
Exploratory GABAa-informed control network modulates hyperarousal brain dynamics in chronic insomnia - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/40610759/
Chronic insomnia disorder is characterized by hyperarousal, a heightened cortical activation pattern that disrupts normal sleep. While hyperarousal has been linked to altered brain state dynamics, the underlying neurobiological mechanisms...
Study reveals that GABAa receptor distribution modulates unstable brain dynamics in chronic insomnia. Incorporating GABAergic data increases network control energy, suggesting a stabilizing role against hyperarousal-related state transitions.
1yr
Comparative efficacy and safety of daridorexant, lemborexant, and suvorexant for insomnia: a systematic review and network meta-analysis - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/40555730/
Considering that there is no evidence that DORAs are associated with physiological tolerance, withdrawal symptoms, or rebound insomnia when abruptly discontinued, and that sleep architecture is not adversely affected, the...